COVID-19 Vaccine Skycovion Among Raft Of New EU Filings
Executive Summary
EU marketing authorization applications for 12 products, including Skycovion, trastuzumab duocarmazine, alpelisib and sparsenta, are now being evaluated by the European Medicines Agency.